InsidersTradesSigma
Track the CVS HEALTH Corp stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, CVS HEALTH Corp has recorded 265 reports. Market capitalisation: €141.1bn. The latest transaction was filed on 29 June 2026 (Retenue fiscale). Among the most active insiders: Shah Prem S. Every trade is accessible without an account.
265
Insider Decl.
n/a
Thresholds
€4m
10 ops.
Buy Volume
€385m
23 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CVS HEALTH Corp Strong Buy (bullish), based on 26 analysts. Average price target: US$111.92.
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,619 of 29,024 companies
35.0
score / 100
Value45
Quality25
FCF yld6.6%
Earn yld1.5%
EV/EBITDA20.2x
ROE6.2%
Gross mgn14%
Net mgn0.4%
Debt/EBITDA8.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations265 total
454 sharesCommon Stock (Restricted)SEC:0000064803-26-000092:0
7,618 shares@ US$90.980.0005% mcap100.0% of flowCommon StockSEC:0000064803-26-000086:0
2,478 shares@ US$90.980.0002% mcap100.0% of flowCommon StockSEC:0000064803-26-000088:0
30,437 shares@ US$93.7750.0021% mcap60.4% of flowCommon StockSEC:0000064803-26-000084:0
1,563 shares@ US$93.5010.0001% mcap3.1% of flowCommon StockSEC:0000064803-26-000084:1
1,983,387 shares@ US$94.4480.14% mcap43.2% of flowCommon StockSEC:0000905148-26-002617:0
151 shares@ US$95.180.0000% mcap0.0% of flowCommon StockSEC:0000905148-26-002617:1
797,628 shares@ US$93.47660.056% mcap17.2% of flowCommon StockSEC:0000905148-26-002617:2
152,691 shares@ US$94.80610.011% mcap3.3% of flowCommon StockSEC:0000905148-26-002617:3
66,881 shares@ US$95.66550.0048% mcap1.5% of flowCommon StockSEC:0000905148-26-002617:4
800 shares@ US$96.28190.0001% mcap0.0% of flowCommon StockSEC:0000905148-26-002617:5
370,462 shares@ US$93.44820.026% mcap8.0% of flowCommon StockSEC:0000905148-26-002617:6
1,447 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000068:0
2,058 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000074:0
1,447 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000072:0
1,447 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000070:0
1,544 shares@ US$97.150.0001% mcap50.0% of flowCommon StockSEC:0000064803-26-000062:0
1,563 shares@ US$97.150.0001% mcap16.7% of flowCommon StockSEC:0000064803-26-000076:0
10,025 shares@ US$71.8210.1% of flowCommon Stock (Restricted)SEC:0000064803-26-000035:0
1,334 shares@ US$72.491.4% of flowCommon StockSEC:0000064803-26-000035:1
11,138 shares@ US$71.8220.0% of flowCommon Stock (Restricted)SEC:0000064803-26-000036:0
3,262 shares@ US$72.495.9% of flowCommon StockSEC:0000064803-26-000036:1
5,569 shares@ US$71.8236.7% of flowCommon Stock (RSUs)SEC:0000064803-26-000037:0
86,326 shares@ US$71.8266.0% of flowCommon Stock (RSUs)SEC:0000064803-26-000038:0
8,029 shares@ US$72.496.2% of flowCommon StockSEC:0000064803-26-000038:1
25 of 265 declarations
关于 CVS HEALTH Corp
CVS Health Corp. (NYSE: CVS) 是美国最大的综合医疗保健公司之一。其商业模式围绕三个互补支柱构建：零售药店和消费者健康、通过CVS Caremark进行的药房福利管理，以及主要通过Aetna提供的健康保险/医疗服务。公司起源于1963年，当时第一家Consumer Value Store在马萨诸塞州洛厄尔成立。自那时起，CVS已从一家健康美容零售商发展成为一个涵盖药房、福利、保险和护理服务的广泛健康平台。其公司总部位于罗德岛州伍恩索基特。 对于欧洲投资者而言，CVS Health 作为一家全国性、防御性的医疗保健特许经营企业脱颖而出，拥有显著的运营范围。公司运营着大约9,000家零售药店、1,000多家步入式和初级保健诊所，一家为约87 million计划成员提供服务的领先PBM，以及一项以老年人为中心的药房护理业务。它还通过传统、自愿和消费者导向的健康保险产品为超过37 million人提供服务。这种多元化为CVS在高度重复、受监管的行业中提供了多个收入来源，同时也在配药、保险和临床服务之间创造了潜在的交叉销售和护理协调协同效应。 从竞争角度来看，CVS受益于密集的配送网络和强大的消费者品牌，但它也面临着显著的行业逆风。这些包括报销压力、不断变化的药房经济、零售药房的激烈竞争以及保险领域医疗成本上升的趋势。公司一直在调整其投资组合以加强综合护理，包括2023年收购Signify Health和Oak Street Health。2025年，CVS还完成了对部分Rite Aid资产的收购，进一步巩固了其药房业务和市场覆盖。这些举措支持了一项以更广泛的护理可及性和医疗保健旅程中更紧密的协调为中心的战略，尽管执行和整合仍然是重要的关注点。 公司近期发展突显了进展和复杂性。CVS在2025年和2026年公布了季度业绩，同时强调了运营执行和更互联的健康战略。与此同时，公司处理了与诉讼相关的费用，以及其部分护理服务组合面临的一些压力。CVS现在正将自身定位为一个更整合的生态系统，连接Aetna、CVS Pharmacy、CVS Caremark和Health Care Delivery。对于投资者而言，该股票提供了对美国医疗保健消费、保险和药房服务的敞口，在美国纽约证券交易所上市，具有主要医疗保健平台通常的大盘稳定性，但也伴随着整合和盈利风险，需要密切关注。
